accountlate-stage clinical trial. Once-weekly taspoglutide showed superiority over exenatide, also known as Byetta, which is co-marketed by Amylin Pharmaceuticals (AMLN.O) and Eli Lilly (LLY.N), Ipsen said in a statement. 'The results showed that taspoglutide...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 1-Roche, Ipsen diabetes drug meets late-stage target
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
